Often times, people outside of the scientific community end up giving diseases common names that negatively affect nations and economies and have serious consequences for peoples’ lives and livelihoods.
Inappropriate disease names that use geographic regions, people’s names or the names of animals — such as Middle East Respiratory Syndrome, Spanish flu, Creutzfeldt-Jakob disease, swine flu, monkey pox and legionnaires — can provoke a backlash against members of particular religious or ethnic communities, create unjustified barriers to travel, commerce and trade and trigger needless slaughtering of food animals.
According to the WHO report, “It is important that whoever first reports on a newly identified human disease uses an appropriate name that is scientifically sound and socially acceptable.”
The international organization suggests naming diseases using generic descriptive terms based on the condition’s symptoms, as well as more specific descriptive terms, like the pathogen that causes the disease, how the disease manifests, who it affects, its severity or its seasonality.
Terms that should be avoided include:
- Geographical locations
- People’s names
- Animal species or food
- References to specific cultures, populations, animals, foods, industries or occupations; or
- Terms that may trigger undue fear
To read the full WHO report on best practices, click here.
More articles on WHO:
WHO: Most countries are unprepared to fight antibiotic-resistant bugs
Sir Liam Donaldson | 50 Experts Leading the Field of Patient Safety 2015
WHO issues first hepatitis B treatment guidelines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit